chr4:54229280:> Detail (hg38) (PDGFRA)
Information
Genome
Assembly | Position |
---|---|
hg19 | chr4:55,095,447-55,164,412 |
hg38 | chr4:54,229,280-54,298,245 |
HGVS
Type | Transcript | Protein |
---|---|---|
Summary
MGeND
Clinical significance | |
Variant entry | |
GWAS entry | |
Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
Clinical Significance | |
Review star | [No Data.] |
Show details |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
Disease | Drug | EL | ET | ED | CS | VO | TR | Pubmed | Links |
---|---|---|---|---|---|---|---|---|---|
gastrointestinal stromal tumor | Imatinib | C |
![]() |
![]() |
Sensitivity/Response | Somatic | 1 | 18955451 | Detail |
DisGeNET
Score | Disease name | Description | Source | Pubmed | Links |
---|---|---|---|---|---|
<0.001 | carcinosarcoma | NA | BeFree | Detail | |
0.002 | Uterine Cervical Neoplasm | NA | GAD | Detail | |
<0.001 | Congenital chromosomal disease | Examination for the common eosinophilia-related cytogenetic abnormalities involv... | BeFree | 25962659 | Detail |
<0.001 | Congenital chromosomal disease | We identified a novel fusion gene, FOXP1-PDGFRA, in a patient with myeloprolifer... | BeFree | 26319757 | Detail |
0.120 | cleft palate | NA | BeFree,CTD_human | Detail | |
<0.001 | colorectal carcinoma | NA | BeFree | Detail | |
0.003 | Colorectal Neoplasms | NA | LHGDN | Detail | |
0.003 | craniosynostosis | NA | BeFree,LHGDN | Detail | |
<0.001 | Phyllodes Tumor | NA | BeFree | Detail | |
<0.001 | Cytomegalovirus Infections | NA | BeFree | Detail | |
<0.001 | Muscular Dystrophy, Duchenne | NA | BeFree | Detail | |
<0.001 | endometriosis | NA | BeFree | Detail | |
0.011 | Eosinophilia | To assess the presence of genetic imbalances in patients with myeloproliferative... | BeFree,LHGDN | 24813417 | Detail |
0.011 | Eosinophilia | We present the first case of T acute lymphoblastic leukemia with a t(4;22)(q12;q... | BeFree,LHGDN | 26095243 | Detail |
0.011 | Eosinophilia | A novel FOXP1-PDGFRA fusion gene in myeloproliferative neoplasm with eosinophili... | BeFree,LHGDN | 26319757 | Detail |
<0.001 | Ependymoma | NA | BeFree | Detail | |
<0.001 | fetal alcohol syndrome | NA | BeFree | Detail | |
0.120 | Fetal Death | NA | CTD_human | Detail | |
0.003 | Fibrosis | NA | LHGDN | Detail | |
<0.001 | Gastrointestinal Neoplasms | NA | BeFree | Detail | |
0.013 | glioblastoma | The extrachromosomal nature of ALEMs explains the observed drastic changes in th... | BeFree,GAD,LHGDN | 25471132 | Detail |
0.013 | glioblastoma | We find evidence of regional mutational heterogeneity in multiple tumors, includ... | BeFree,GAD,LHGDN | 25608559 | Detail |
0.011 | Glioma | Ganglioside GD3 Enhances Invasiveness of Gliomas by Forming a Complex with Plate... | BeFree,LHGDN | 25940087 | Detail |
0.011 | Glioma | We specifically demonstrate that loss of CTCF at a domain boundary permits a con... | BeFree,LHGDN | 26700815 | Detail |
<0.001 | Hematological Disease | NA | BeFree | Detail | |
0.003 | Diaphragmatic hernia | NA | LHGDN | Detail | |
<0.001 | Histiocytosis, Langerhans-Cell | NA | BeFree | Detail | |
0.003 | Hodgkin Disease | NA | LHGDN | Detail | |
0.002 | Hyperparathyroidism, Secondary | NA | GAD | Detail | |
<0.001 | Intestinal Neoplasms | NA | BeFree | Detail | |
0.001 | Fibroid Tumor | To evaluate possible diagnostic utility of SDHB immunohistochemistry in the diff... | BeFree | 25205505 | Detail |
<0.001 | leiomyosarcoma | To evaluate possible diagnostic utility of SDHB immunohistochemistry in the diff... | BeFree | 25205505 | Detail |
0.004 | leukemia | NA | BeFree,LHGDN | Detail | |
0.002 | chronic lymphocytic leukemia | NA | GAD | Detail | |
<0.001 | lymphoid leukemia | NA | BeFree | Detail | |
<0.001 | Acute lymphocytic leukemia | NA | BeFree | Detail | |
0.004 | Leukemia, Myelocytic, Acute | NA | BeFree,LHGDN | Detail | |
0.002 | myeloid leukemia | NA | GAD | Detail | |
0.003 | Myeloid Leukemia, Chronic | To assess the presence of genetic imbalances in patients with myeloproliferative... | BeFree | 24813417 | Detail |
<0.001 | Leukemia, Myelomonocytic, Chronic | NA | BeFree | Detail | |
<0.001 | Liver diseases | NA | BeFree | Detail | |
0.003 | Liver neoplasms | Similarly, an in vivo assay showed that PDGFRα overexpression in hepatoma cells ... | BeFree,GAD | 25333264 | Detail |
0.003 | Liver neoplasms | PDE5 and PDGFRα/β were over-expressed in liver tumors compared to normal liver t... | BeFree,GAD | 25704960 | Detail |
0.120 | Lung diseases | NA | CTD_human | Detail | |
0.003 | Lung Neoplasms | NA | LHGDN | Detail | |
<0.001 | lupus nephritis | NA | BeFree | Detail | |
0.002 | Lymphatic Metastasis | NA | GAD | Detail | |
0.006 | lymphoma | NA | BeFree,LHGDN | Detail | |
<0.001 | Malignant neoplasm of stomach | NA | BeFree | Detail | |
0.001 | mastocytosis | NA | BeFree | Detail | |
0.124 | medulloblastoma | Here, we report the subgroup specific expression of PDGFRα and PDGFRβ and their ... | BeFree,CTD_human,LHGDN | 25576913 | Detail |
0.002 | melanoma | NA | BeFree | Detail | |
<0.001 | meningioma | NA | BeFree | Detail | |
0.003 | Meningomyelocele | NA | BeFree,LHGDN | Detail | |
0.003 | Mixed Salivary Gland Tumor | NA | LHGDN | Detail | |
0.008 | Myeloproliferative disease | This study also found losses at 11q13.3 in 26% of patients with MPN-Ph- and in 1... | BeFree,LHGDN | 24813417 | Detail |
0.008 | Myeloproliferative disease | A novel FOXP1-PDGFRA fusion gene in myeloproliferative neoplasm with eosinophili... | BeFree,LHGDN | 26319757 | Detail |
0.009 | Neoplasm Metastasis | Nuclear FGFR2 expression was associated with increased risk of metastasis (odds ... | BeFree,LHGDN | 24390213 | Detail |
0.009 | Neoplasm Metastasis | The difference between succinate dehydrogenase subunit A-mutant gastrointestinal... | BeFree,LHGDN | 25188872 | Detail |
0.009 | Neoplasm Metastasis | Metastatic tumors more frequently overexpressed PDGFR-α compared to localized tu... | BeFree,LHGDN | 25976141 | Detail |
0.009 | Neoplasm Metastasis | PDGFRA, CAV1, and GJA-1 were revealed as key node genes for cervical cancer inva... | BeFree,LHGDN | 26189259 | Detail |
0.002 | Neoplasm Recurrence, Local | NA | GAD | Detail | |
0.007 | Neural Tube Defects | NA | GAD,LHGDN | Detail | |
0.001 | neurofibroma | NA | BeFree | Detail | |
0.002 | neurofibromatosis 1 | The molecular biology of these GIST, originally defined as KIT/PDGFRA wild-type ... | BeFree | 25239601 | Detail |
0.002 | neurofibromatosis 1 | Furthermore, KIT/PDGFRA wt-GIST are observed in the context of hereditary syndro... | BeFree | 25831232 | Detail |
0.001 | oligodendroglioma | NA | BeFree | Detail | |
<0.001 | Degenerative polyarthritis | NA | BeFree | Detail | |
<0.001 | osteosarcoma | NA | BeFree | Detail | |
<0.001 | ovarian carcinoma | NA | BeFree | Detail | |
0.002 | Pancreatic Neoplasm | NA | GAD | Detail | |
<0.001 | polyps | NA | BeFree | Detail | |
0.003 | Prostatic Neoplasms | NA | LHGDN | Detail | |
0.120 | Congenital abnormality of respiratory system | NA | CTD_human | Detail | |
<0.001 | rhabdomyosarcoma | NA | BeFree | Detail | |
<0.001 | systemic scleroderma | NA | BeFree | Detail | |
0.080 | Skin Ulcer | NA | RGD | Detail | |
0.001 | Stomach Neoplasms | NA | BeFree | Detail | |
<0.001 | gastric ulcer | NA | BeFree | Detail | |
0.080 | Cerebrovascular accident | NA | RGD | Detail | |
<0.001 | synovial sarcoma | To evaluate possible diagnostic utility of SDHB immunohistochemistry in the diff... | BeFree | 25205505 | Detail |
0.002 | Tobacco use disorder | NA | GAD | Detail | |
<0.001 | urticaria pigmentosa | NA | BeFree | Detail | |
<0.001 | Uterine Fibroids | To evaluate possible diagnostic utility of SDHB immunohistochemistry in the diff... | BeFree | 25205505 | Detail |
0.005 | vitiligo | NA | BeFree,GAD | Detail | |
<0.001 | T-Cell Lymphoma | NA | BeFree | Detail | |
<0.001 | peripheral T-cell lymphoma | NA | BeFree | Detail | |
0.080 | oligohydramnios | NA | RGD | Detail | |
0.126 | spina bifida | NA | BeFree,CTD_human,GAD,LHGDN | Detail | |
<0.001 | severe combined immunodeficiency | NA | BeFree | Detail | |
<0.001 | acute leukemia | NA | BeFree | Detail | |
<0.001 | Codependency | NA | BeFree | Detail | |
0.002 | Small cell carcinoma of lung | NA | BeFree | Detail | |
<0.001 | Granulocytic Sarcoma | NA | BeFree | Detail | |
<0.001 | uterine cancer | NA | BeFree | Detail | |
<0.001 | Neurofibromatoses | NA | BeFree | Detail | |
0.001 | Tumor Progression | Overexpression of platelet-derived growth factor receptor alpha promotes tumor p... | BeFree | 25333264 | Detail |
<0.001 | myxopapillary ependymoma | NA | BeFree | Detail | |
<0.001 | Eosinophilic leukemia | NA | BeFree | Detail | |
<0.001 | Lymphomatoid Papulosis | NA | BeFree | Detail | |
<0.001 | adenosquamous carcinoma | NA | BeFree | Detail | |
0.003 | endometrial stromal sarcoma | To evaluate possible diagnostic utility of SDHB immunohistochemistry in the diff... | BeFree,LHGDN | 25205505 | Detail |
0.120 | Chondrosarcoma, Mesenchymal | NA | CTD_human | Detail | |
0.003 | alveolar rhabdomyosarcoma | NA | BeFree,LHGDN | Detail | |
<0.001 | embryonal carcinoma | NA | BeFree | Detail | |
<0.001 | Neuroectodermal Tumor, Primitive | NA | BeFree | Detail | |
<0.001 | Carcinoma, Neuroendocrine | Synchronous poorly-differentiated neuroendocrine carcinoma and gastrointestinal ... | BeFree | 25674291 | Detail |
<0.001 | cholangiocarcinoma | NA | BeFree | Detail | |
<0.001 | subependymal glioma | NA | BeFree | Detail | |
0.003 | gliosarcoma | NA | BeFree,LHGDN | Detail | |
0.003 | Nerve Sheath Tumors | NA | BeFree,LHGDN | Detail | |
<0.001 | plexiform neurofibroma | NA | BeFree | Detail | |
<0.001 | Neuroendocrine Tumors | NA | BeFree | Detail | |
0.007 | Mastocytosis, Systemic | NA | BeFree,LHGDN | Detail | |
0.080 | congenital diaphragmatic hernia | NA | MGD | Detail | |
<0.001 | pancreatic carcinoma | NA | BeFree | Detail | |
<0.001 | Leiomyoma of esophagus | NA | BeFree | Detail | |
0.616 | Gastrointestinal Stromal Tumors | We therefore consider imatinib mesylate an appropriate therapy for c- kit negati... | BeFree,CLINVAR,CTD_human,GAD,LHGDN,ORPHANET,UNIPROT | 24635438 | Detail |
0.616 | Gastrointestinal Stromal Tumors | In gastrointestinal stromal tumors (GIST), molecularly targeted therapies, start... | BeFree,CLINVAR,CTD_human,GAD,LHGDN,ORPHANET,UNIPROT | 24727986 | Detail |
0.616 | Gastrointestinal Stromal Tumors | Gastrointestinal stromal tumors (GISTs) are mesenchymal tumors of the gastrointe... | BeFree,CLINVAR,CTD_human,GAD,LHGDN,ORPHANET,UNIPROT | 24802226 | Detail |
0.616 | Gastrointestinal Stromal Tumors | Approximately 7.5% of gastric gastrointestinal stromal tumors are SDH-deficient ... | BeFree,CLINVAR,CTD_human,GAD,LHGDN,ORPHANET,UNIPROT | 24886695 | Detail |
0.616 | Gastrointestinal Stromal Tumors | The genetic landscape of gastrointestinal stromal tumor lacking KIT and PDGFRA m... | BeFree,CLINVAR,CTD_human,GAD,LHGDN,ORPHANET,UNIPROT | 25027296 | Detail |
0.616 | Gastrointestinal Stromal Tumors | We propose that these KIT/PDGFRA/SDH/RAS-P WT GIST tumors be designated as quadr... | BeFree,CLINVAR,CTD_human,GAD,LHGDN,ORPHANET,UNIPROT | 25165019 | Detail |
0.616 | Gastrointestinal Stromal Tumors | Patients with metastatic KIT/PDGFRA wild-type succinate dehydrogenase-deficient ... | BeFree,CLINVAR,CTD_human,GAD,LHGDN,ORPHANET,UNIPROT | 25188872 | Detail |
0.616 | Gastrointestinal Stromal Tumors | Furthermore, SDHB immunohistochemistry alone may be misleading in excluding tumo... | BeFree,CLINVAR,CTD_human,GAD,LHGDN,ORPHANET,UNIPROT | 25205505 | Detail |
0.616 | Gastrointestinal Stromal Tumors | Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-t... | BeFree,CLINVAR,CTD_human,GAD,LHGDN,ORPHANET,UNIPROT | 25239601 | Detail |
0.616 | Gastrointestinal Stromal Tumors | There is growing evidence of phenotype-genotype (KIT, platelet-derived growth fa... | BeFree,CLINVAR,CTD_human,GAD,LHGDN,ORPHANET,UNIPROT | 25414046 | Detail |
0.616 | Gastrointestinal Stromal Tumors | Novel oncogene and tumor suppressor mutations in KIT and PDGFRA wild type gastro... | BeFree,CLINVAR,CTD_human,GAD,LHGDN,ORPHANET,UNIPROT | 25427437 | Detail |
0.616 | Gastrointestinal Stromal Tumors | In the current study, we set out to explore the frequency and distribution patte... | BeFree,CLINVAR,CTD_human,GAD,LHGDN,ORPHANET,UNIPROT | 25481675 | Detail |
0.616 | Gastrointestinal Stromal Tumors | SDH-deficient gastrointestinal stromal tumors (dSDH GISTs) collectively manifest... | BeFree,CLINVAR,CTD_human,GAD,LHGDN,ORPHANET,UNIPROT | 25540324 | Detail |
0.616 | Gastrointestinal Stromal Tumors | Activating mutations in either KIT or PDGFRA are present in approximately 90% of... | BeFree,CLINVAR,CTD_human,GAD,LHGDN,ORPHANET,UNIPROT | 25673643 | Detail |
0.616 | Gastrointestinal Stromal Tumors | This is the first documented case of synchronous gastric GIST and NEC with the e... | BeFree,CLINVAR,CTD_human,GAD,LHGDN,ORPHANET,UNIPROT | 25674291 | Detail |
0.616 | Gastrointestinal Stromal Tumors | Classification of KIT/PDGFRA wild-type gastrointestinal stromal tumors: implicat... | BeFree,CLINVAR,CTD_human,GAD,LHGDN,ORPHANET,UNIPROT | 25831232 | Detail |
0.616 | Gastrointestinal Stromal Tumors | Gastrointestinal stromal tumors (GIST) are the most common adult sarcomas and th... | BeFree,CLINVAR,CTD_human,GAD,LHGDN,ORPHANET,UNIPROT | 25836719 | Detail |
0.616 | Gastrointestinal Stromal Tumors | Platelet-Derived Growth Factor Receptor-α Regulates Proliferation of Gastrointes... | BeFree,CLINVAR,CTD_human,GAD,LHGDN,ORPHANET,UNIPROT | 25865047 | Detail |
0.616 | Gastrointestinal Stromal Tumors | Gastrointestinal stromal tumours (GIST) are mainly characterised by the presence... | BeFree,CLINVAR,CTD_human,GAD,LHGDN,ORPHANET,UNIPROT | 25880691 | Detail |
0.616 | Gastrointestinal Stromal Tumors | Mutation was a significant prognostic indicator of overall survival in naive, lo... | BeFree,CLINVAR,CTD_human,GAD,LHGDN,ORPHANET,UNIPROT | 25970686 | Detail |
0.616 | Gastrointestinal Stromal Tumors | Gastrointestinal stromal tumors (GISTs) develop from interstitial cells of Cajal... | BeFree,CLINVAR,CTD_human,GAD,LHGDN,ORPHANET,UNIPROT | 26243012 | Detail |
<0.001 | Papillary thyroid carcinoma | NA | BeFree | Detail | |
<0.001 | Fibrosis, Liver | Studies elucidating PDGFRα signaling in processes ranging from profibrotic signa... | BeFree | 25700367 | Detail |
0.080 | Hyperoxia | NA | RGD | Detail | |
<0.001 | mixed gliomas | NA | BeFree | Detail | |
<0.001 | Polyp of gallbladder | NA | BeFree | Detail | |
0.002 | Carcinoma, Small Cell | NA | BeFree | Detail | |
<0.001 | Metastatic melanoma | NA | BeFree | Detail | |
<0.001 | Liver and Intrahepatic Biliary Tract Carcinoma | Studies elucidating PDGFRα signaling in processes ranging from profibrotic signa... | BeFree | 25700367 | Detail |
<0.001 | Solid tumour | NA | BeFree | Detail | |
<0.001 | Eosinophilic granulomatous polyp | NA | BeFree | Detail | |
<0.001 | inflammatory myofibroblastic tumor | To evaluate possible diagnostic utility of SDHB immunohistochemistry in the diff... | BeFree | 25205505 | Detail |
<0.001 | anaplastic astrocytoma | NA | BeFree | Detail | |
<0.001 | anaplastic oligodendroglioma | We find evidence of regional mutational heterogeneity in multiple tumors, includ... | BeFree | 25608559 | Detail |
<0.001 | uterine corpus sarcoma | NA | BeFree | Detail | |
0.121 | Regular astigmatism - corneal | NA | BeFree,GWASCAT | Detail | |
<0.001 | Chronic liver disease | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of liver | Studies elucidating PDGFRα signaling in processes ranging from profibrotic signa... | BeFree | 25700367 | Detail |
<0.001 | cervical adenosquamous carcinoma | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of pancreas | NA | BeFree | Detail | |
<0.001 | Malignant neoplasm of prostate | NA | BeFree | Detail | |
<0.001 | Hematopoietic Neoplasms | NA | BeFree | Detail | |
<0.001 | Hematologic Neoplasms | NA | BeFree | Detail | |
0.120 | Craniofacial Abnormalities | NA | CTD_human | Detail | |
<0.001 | dermatofibrosarcoma protuberans | NA | BeFree | Detail | |
<0.001 | Skeletal dysplasia | NA | BeFree | Detail | |
<0.001 | Chromosome 8, trisomy | NA | BeFree | Detail | |
<0.001 | Secondary malignant neoplasm of liver | NA | BeFree | Detail | |
<0.001 | Recurrent tumor | NA | BeFree | Detail | |
<0.001 | Malignant glioma | NA | BeFree | Detail | |
<0.001 | Osteosarcoma of bone | NA | BeFree | Detail | |
0.002 | Carcinogenesis | NA | BeFree | Detail | |
<0.001 | prostate carcinoma | NA | BeFree | Detail | |
<0.001 | Epithelial ovarian cancer | NA | BeFree | Detail | |
<0.001 | Refractory cancer | NA | BeFree | Detail | |
<0.001 | breast carcinoma | NA | BeFree | Detail | |
0.002 | Malignant neoplasm of gastrointestinal tract | NA | GAD | Detail | |
<0.001 | Secondary malignant neoplasm of lymph node | NA | BeFree | Detail | |
<0.001 | stomach carcinoma | NA | BeFree | Detail | |
<0.001 | Carcinoma of bladder | NA | BeFree | Detail | |
0.003 | Hypereosinophilia | NA | BeFree | Detail | |
<0.001 | Brain Tumor, Primary | NA | BeFree | Detail | |
0.001 | Well Differentiated Oligodendroglioma | NA | BeFree | Detail | |
<0.001 | malignant peripheral nerve sheath tumor | NA | BeFree | Detail | |
0.001 | Rhabdoid Tumor of the Kidney | We found that decreased miR-218 expression in GBM cells also increased the expre... | BeFree | 25943352 | Detail |
0.006 | ovarian neoplasm | NA | BeFree,LHGDN | Detail | |
<0.001 | Squamous cell carcinoma of the head and neck | NA | BeFree | Detail | |
0.002 | sarcoma | NA | BeFree | Detail | |
<0.001 | Lymphocytic infiltration | NA | BeFree | Detail | |
<0.001 | large cell neuroendocrine carcinoma | NA | BeFree | Detail | |
<0.001 | Solitary fibrous tumor | Furthermore, SDHB immunohistochemistry alone may be misleading in excluding tumo... | BeFree | 25205505 | Detail |
<0.001 | Disorder of skull | NA | BeFree | Detail | |
<0.001 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | NA | BeFree | Detail | |
0.002 | Chronic myeloproliferative disorder | This study also found losses at 11q13.3 in 26% of patients with MPN-Ph- and in 1... | BeFree | 24813417 | Detail |
0.002 | Chronic myeloproliferative disorder | A novel FOXP1-PDGFRA fusion gene in myeloproliferative neoplasm with eosinophili... | BeFree | 26319757 | Detail |
<0.001 | Precursor T cell lymphoblastic leukemia/lymphoblastic lymphoma | BCR-PDGFRA fusion in a T lymphoblastic leukemia/lymphoma. | BeFree | 26095243 | Detail |
0.009 | Eosinophilic disorder | To assess the presence of genetic imbalances in patients with myeloproliferative... | BeFree | 24813417 | Detail |
0.009 | Eosinophilic disorder | We present the first case of T acute lymphoblastic leukemia with a t(4;22)(q12;q... | BeFree | 26095243 | Detail |
0.009 | Eosinophilic disorder | A novel FOXP1-PDGFRA fusion gene in myeloproliferative neoplasm with eosinophili... | BeFree | 26319757 | Detail |
0.001 | Gastric Gastrointestinal Stromal Tumor | Synchronous poorly-differentiated neuroendocrine carcinoma and gastrointestinal ... | BeFree | 25674291 | Detail |
0.001 | mesenchymal cell neoplasm | Gastrointestinal stromal tumors (GISTs) are mesenchymal tumors of the gastrointe... | BeFree | 24802226 | Detail |
0.001 | mesenchymal cell neoplasm | Furthermore, SDHB immunohistochemistry alone may be misleading in excluding tumo... | BeFree | 25205505 | Detail |
<0.001 | Testicular Germ Cell Tumor | We reveal possible drivers of TGCT pathogenesis, such as mutated PDGFRA, potenti... | BeFree | 25748235 | Detail |
0.006 | Mammary Neoplasms | NA | BeFree,LHGDN | Detail | |
<0.001 | Hepatocarcinogenesis | We and others have examined that upregulation of PDGFRα might be involved in hep... | BeFree | 25333264 | Detail |
<0.001 | Primary Glioblastoma | NA | BeFree | Detail | |
<0.001 | Secondary Glioblastoma | NA | BeFree | Detail | |
<0.001 | Xenograft Model | NA | BeFree | Detail | |
<0.001 | colorectal cancer | NA | BeFree | Detail | |
<0.001 | Glioblastoma multiforme | NA | BeFree | Detail | |
0.008 | Disorder characterized by eosinophilia | To assess the presence of genetic imbalances in patients with myeloproliferative... | BeFree | 24813417 | Detail |
0.008 | Disorder characterized by eosinophilia | We present the first case of T acute lymphoblastic leukemia with a t(4;22)(q12;q... | BeFree | 26095243 | Detail |
0.008 | Disorder characterized by eosinophilia | A novel FOXP1-PDGFRA fusion gene in myeloproliferative neoplasm with eosinophili... | BeFree | 26319757 | Detail |
<0.001 | bone sarcoma | NA | BeFree | Detail | |
<0.001 | Intimal sarcoma | NA | BeFree | Detail | |
<0.001 | PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA | NA | BeFree | Detail | |
<0.001 | VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding) | NA | BeFree | Detail | |
<0.001 | lateral meningocele syndrome | To evaluate possible diagnostic utility of SDHB immunohistochemistry in the diff... | BeFree | 25205505 | Detail |
0.002 | Carney triad | NA | BeFree | Detail | |
<0.001 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | We present the first case of T acute lymphoblastic leukemia with a t(4;22)(q12;q... | BeFree | 26095243 | Detail |
0.003 | Precursor Cell Lymphoblastic Leukemia Lymphoma | NA | BeFree,LHGDN | Detail | |
0.001 | liver carcinoma | Overexpression of platelet-derived growth factor receptor alpha promotes tumor p... | BeFree | 25333264 | Detail |
0.001 | myeloid neoplasm | To assess the presence of genetic imbalances in patients with myeloproliferative... | BeFree | 24813417 | Detail |
<0.001 | Fetal Alcohol Spectrum Disorders | NA | BeFree | Detail | |
<0.001 | Triple Negative Breast Neoplasms | The three receptor tyrosine kinases c-KIT, VEGFR2 and PDGFRα, closely spaced at ... | BeFree | 25025175 | Detail |
<0.001 | Triple Negative Breast Neoplasms | C-kit and PDGFRA gene mutations in triple negative breast cancer. | BeFree | 25120810 | Detail |
0.003 | Infection | NA | LHGDN | Detail | |
0.120 | Leukemia, acute lymphoblastic, susceptibility to, 3 | NA | ORPHANET | Detail | |
<0.001 | Proneural Glioblastoma | NA | BeFree | Detail | |
<0.001 | adenocarcinoma | NA | BeFree | Detail | |
0.002 | Alzheimer's disease | NA | GAD | Detail | |
0.002 | Aneuploidy | NA | GAD | Detail | |
<0.001 | rheumatoid arthritis | NA | BeFree | Detail | |
0.003 | asthma | NA | BeFree,GAD | Detail | |
0.002 | astigmatism | NA | GAD | Detail | |
0.007 | Astrocytoma | NA | BeFree,LHGDN | Detail | |
0.002 | atherosclerosis | NA | GAD | Detail | |
0.002 | bipolar disorder | NA | GAD | Detail | |
<0.001 | Malignant neoplasm of urinary bladder | NA | BeFree | Detail | |
<0.001 | borderline personality disorder | NA | BeFree | Detail | |
0.003 | Brain Neoplasms | NA | BeFree,GAD | Detail | |
<0.001 | Malignant neoplasm of breast | NA | BeFree | Detail | |
<0.001 | bronchopulmonary dysplasia | NA | BeFree | Detail | |
0.003 | Carcinoid Tumor | NA | BeFree,LHGDN | Detail | |
0.004 | Merkel cell carcinoma | NA | BeFree,LHGDN | Detail | |
<0.001 | Non-small cell lung carcinoma | NA | BeFree | Detail |
Annotation
Annotations
Descrption | Source | Links |
---|---|---|
These four patients were part of a larger cohort of 397 patients with incurable (i.e. metastatic or ... | CIViC Evidence | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Examination for the common eosinophilia-related cytogenetic abnormalities involving the genes PDGFRA... | DisGeNET | Detail |
We identified a novel fusion gene, FOXP1-PDGFRA, in a patient with myeloproliferative neoplasm (MPN)... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
To assess the presence of genetic imbalances in patients with myeloproliferative neoplasms (MPNs), 3... | DisGeNET | Detail |
We present the first case of T acute lymphoblastic leukemia with a t(4;22)(q12;q11.2) involving the ... | DisGeNET | Detail |
A novel FOXP1-PDGFRA fusion gene in myeloproliferative neoplasm with eosinophilia. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The extrachromosomal nature of ALEMs explains the observed drastic changes in the amounts of mutated... | DisGeNET | Detail |
We find evidence of regional mutational heterogeneity in multiple tumors, including mutations in TP5... | DisGeNET | Detail |
Ganglioside GD3 Enhances Invasiveness of Gliomas by Forming a Complex with Platelet-derived Growth F... | DisGeNET | Detail |
We specifically demonstrate that loss of CTCF at a domain boundary permits a constitutive enhancer t... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
To evaluate possible diagnostic utility of SDHB immunohistochemistry in the differential diagnostics... | DisGeNET | Detail |
To evaluate possible diagnostic utility of SDHB immunohistochemistry in the differential diagnostics... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
To assess the presence of genetic imbalances in patients with myeloproliferative neoplasms (MPNs), 3... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Similarly, an in vivo assay showed that PDGFRα overexpression in hepatoma cells exhibited remarkably... | DisGeNET | Detail |
PDE5 and PDGFRα/β were over-expressed in liver tumors compared to normal liver tissue. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Here, we report the subgroup specific expression of PDGFRα and PDGFRβ and their associated biologica... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
This study also found losses at 11q13.3 in 26% of patients with MPN-Ph- and in 19p13.11 in two of th... | DisGeNET | Detail |
A novel FOXP1-PDGFRA fusion gene in myeloproliferative neoplasm with eosinophilia. | DisGeNET | Detail |
Nuclear FGFR2 expression was associated with increased risk of metastasis (odds ratio (OR)=7.61, P=0... | DisGeNET | Detail |
The difference between succinate dehydrogenase subunit A-mutant gastrointestinal stromal tumors and ... | DisGeNET | Detail |
Metastatic tumors more frequently overexpressed PDGFR-α compared to localized tumors (75% versus 31%... | DisGeNET | Detail |
PDGFRA, CAV1, and GJA-1 were revealed as key node genes for cervical cancer invasion and metastasis. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
The molecular biology of these GIST, originally defined as KIT/PDGFRA wild-type (WT), is complex due... | DisGeNET | Detail |
Furthermore, KIT/PDGFRA wt-GIST are observed in the context of hereditary syndromes, such as neurofi... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
To evaluate possible diagnostic utility of SDHB immunohistochemistry in the differential diagnostics... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
To evaluate possible diagnostic utility of SDHB immunohistochemistry in the differential diagnostics... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Overexpression of platelet-derived growth factor receptor alpha promotes tumor progression and indic... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
To evaluate possible diagnostic utility of SDHB immunohistochemistry in the differential diagnostics... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Synchronous poorly-differentiated neuroendocrine carcinoma and gastrointestinal stromal tumor of the... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We therefore consider imatinib mesylate an appropriate therapy for c- kit negative GIST bearing PDGF... | DisGeNET | Detail |
In gastrointestinal stromal tumors (GIST), molecularly targeted therapies, starting with imatinib, a... | DisGeNET | Detail |
Gastrointestinal stromal tumors (GISTs) are mesenchymal tumors of the gastrointestinal tract, which ... | DisGeNET | Detail |
Approximately 7.5% of gastric gastrointestinal stromal tumors are SDH-deficient and not driven by KI... | DisGeNET | Detail |
The genetic landscape of gastrointestinal stromal tumor lacking KIT and PDGFRA mutations. | DisGeNET | Detail |
We propose that these KIT/PDGFRA/SDH/RAS-P WT GIST tumors be designated as quadruple wild-type (WT) ... | DisGeNET | Detail |
Patients with metastatic KIT/PDGFRA wild-type succinate dehydrogenase-deficient gastrointestinal str... | DisGeNET | Detail |
Furthermore, SDHB immunohistochemistry alone may be misleading in excluding tumors other than GIST (... | DisGeNET | Detail |
Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST). | DisGeNET | Detail |
There is growing evidence of phenotype-genotype (KIT, platelet-derived growth factor receptor-alpha,... | DisGeNET | Detail |
Novel oncogene and tumor suppressor mutations in KIT and PDGFRA wild type gastrointestinal stromal t... | DisGeNET | Detail |
In the current study, we set out to explore the frequency and distribution pattern of c-KIT (exons 9... | DisGeNET | Detail |
SDH-deficient gastrointestinal stromal tumors (dSDH GISTs) collectively manifest similar phenotypes,... | DisGeNET | Detail |
Activating mutations in either KIT or PDGFRA are present in approximately 90% of gastrointestinal st... | DisGeNET | Detail |
This is the first documented case of synchronous gastric GIST and NEC with the examination of protei... | DisGeNET | Detail |
Classification of KIT/PDGFRA wild-type gastrointestinal stromal tumors: implications for therapy. | DisGeNET | Detail |
Gastrointestinal stromal tumors (GIST) are the most common adult sarcomas and the oncogenic driver i... | DisGeNET | Detail |
Platelet-Derived Growth Factor Receptor-α Regulates Proliferation of Gastrointestinal Stromal Tumor ... | DisGeNET | Detail |
Gastrointestinal stromal tumours (GIST) are mainly characterised by the presence of activating mutat... | DisGeNET | Detail |
Mutation was a significant prognostic indicator of overall survival in naive, localized GISTs (P<0.0... | DisGeNET | Detail |
Gastrointestinal stromal tumors (GISTs) develop from interstitial cells of Cajal (ICCs) mainly by ac... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Studies elucidating PDGFRα signaling in processes ranging from profibrotic signaling, angiogenesis, ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Studies elucidating PDGFRα signaling in processes ranging from profibrotic signaling, angiogenesis, ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
To evaluate possible diagnostic utility of SDHB immunohistochemistry in the differential diagnostics... | DisGeNET | Detail |
NA | DisGeNET | Detail |
We find evidence of regional mutational heterogeneity in multiple tumors, including mutations in TP5... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Studies elucidating PDGFRα signaling in processes ranging from profibrotic signaling, angiogenesis, ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
We found that decreased miR-218 expression in GBM cells also increased the expression of genes encod... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Furthermore, SDHB immunohistochemistry alone may be misleading in excluding tumors other than GIST (... | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
This study also found losses at 11q13.3 in 26% of patients with MPN-Ph- and in 19p13.11 in two of th... | DisGeNET | Detail |
A novel FOXP1-PDGFRA fusion gene in myeloproliferative neoplasm with eosinophilia. | DisGeNET | Detail |
BCR-PDGFRA fusion in a T lymphoblastic leukemia/lymphoma. | DisGeNET | Detail |
To assess the presence of genetic imbalances in patients with myeloproliferative neoplasms (MPNs), 3... | DisGeNET | Detail |
We present the first case of T acute lymphoblastic leukemia with a t(4;22)(q12;q11.2) involving the ... | DisGeNET | Detail |
A novel FOXP1-PDGFRA fusion gene in myeloproliferative neoplasm with eosinophilia. | DisGeNET | Detail |
Synchronous poorly-differentiated neuroendocrine carcinoma and gastrointestinal stromal tumor of the... | DisGeNET | Detail |
Gastrointestinal stromal tumors (GISTs) are mesenchymal tumors of the gastrointestinal tract, which ... | DisGeNET | Detail |
Furthermore, SDHB immunohistochemistry alone may be misleading in excluding tumors other than GIST (... | DisGeNET | Detail |
We reveal possible drivers of TGCT pathogenesis, such as mutated PDGFRA, potentially with therapeuti... | DisGeNET | Detail |
NA | DisGeNET | Detail |
We and others have examined that upregulation of PDGFRα might be involved in hepatocarcinogenesis. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
To assess the presence of genetic imbalances in patients with myeloproliferative neoplasms (MPNs), 3... | DisGeNET | Detail |
We present the first case of T acute lymphoblastic leukemia with a t(4;22)(q12;q11.2) involving the ... | DisGeNET | Detail |
A novel FOXP1-PDGFRA fusion gene in myeloproliferative neoplasm with eosinophilia. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
To evaluate possible diagnostic utility of SDHB immunohistochemistry in the differential diagnostics... | DisGeNET | Detail |
NA | DisGeNET | Detail |
We present the first case of T acute lymphoblastic leukemia with a t(4;22)(q12;q11.2) involving the ... | DisGeNET | Detail |
NA | DisGeNET | Detail |
Overexpression of platelet-derived growth factor receptor alpha promotes tumor progression and indic... | DisGeNET | Detail |
To assess the presence of genetic imbalances in patients with myeloproliferative neoplasms (MPNs), 3... | DisGeNET | Detail |
NA | DisGeNET | Detail |
The three receptor tyrosine kinases c-KIT, VEGFR2 and PDGFRα, closely spaced at 4q12, show increased... | DisGeNET | Detail |
C-kit and PDGFRA gene mutations in triple negative breast cancer. | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
---|
Overlapped Transcript
Gene | Transcript ID | Chromosome | Start | Stop | Links |
---|
- Gene
- -
- Genome
- hg38
- Position
- chr4:54,229,280-54,298,245
- Variant Type
- snv
- Variant (CIViC) (CIViC Variant)
- DIM842_844DEL
- Variant URL (CIViC Variant)
- https://civic.genome.wustl.edu/links/variants/1518
- Variant (CIViC) (CIViC Variant)
- EXON 18 MUTATION
- Variant URL (CIViC Variant)
- https://civic.genome.wustl.edu/links/variants/2623
Genome browser